Cargando…

Evaluation of the Genmark ePlex® and QIAstat-Dx® respiratory pathogen panels in detecting bacterial targets in lower respiratory tract specimens

BACKGROUND: The ePlex® and QIAstat-Dx® respiratory pathogen panels detect multiple respiratory pathogens, mainly viruses but also Legionella pneumophila, Mycoplasma pneumoniae and Bordetella pertussis. The assays have been marketed for use in nasopharyngeal swab specimens. For diagnosing bacterial p...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Asten, Suzanne A. V., Boers, Stefan A., de Groot, Jolanda D. F., Schuurman, R., Claas, Eric C. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390116/ https://www.ncbi.nlm.nih.gov/pubmed/34445973 http://dx.doi.org/10.1186/s12866-021-02289-w

Ejemplares similares

359. The Clinical Utility of the GenMark Dx ePlex® Fungal Blood Culture Identification Panel
por: Carmona, Stefania, et al.
Publicado: (2022)

Clinical Performance of the Novel GenMark Dx ePlex Blood Culture ID Gram-Positive Panel
por: Carroll, Karen C., et al.
Publicado: (2020)

214. Prospective Evaluation of the GenMark Dx ePlex(®) Blood Culture Identification Gram Negative Panel
por: Meeder, Jeremy, et al.
Publicado: (2021)

200. Prospective Evaluation of the GenMark Dx ePlex(®) Blood Culture Identification Gram Positive Panel
por: Meeder, Jeremy, et al.
Publicado: (2021)

Test Performance and Potential Clinical Utility of the GenMark Dx ePlex Blood Culture Identification Gram-Negative Panel
por: McCarty, T. P., et al.
Publicado: (2023)

The impact of GenMark Dx ePlex blood-culture identification on the treatment and outcomes of gram-positive bacteremia
por: Kiszla, B. Matthew, et al.
Publicado: (2022)

A Multicenter Clinical Study To Demonstrate the Diagnostic Accuracy of the GenMark Dx ePlex Blood Culture Identification Gram-Negative Panel
por: Wolk, Donna M., et al.
Publicado: (2021)

1022. Evaluating the Impact of GenMark Dx ePlex® Blood Culture Identification (BCID) on Gram-negative Bloodstream Infections
por: Cumagun, Pia, et al.
Publicado: (2021)

Multicenter Evaluation of QIAstat-Dx Respiratory Panel V2 for Detection of Viral and Bacterial Respiratory Pathogens
por: Boers, Stefan A., et al.
Publicado: (2020)

Performance of the QIAstat-Dx Gastrointestinal Panel for Diagnosing Infectious Gastroenteritis
por: Boers, Stefan A., et al.
Publicado: (2020)

Multicenter Evaluation of the QIAstat-Dx Respiratory Panel for Detection of Viruses and Bacteria in Nasopharyngeal Swab Specimens
por: Leber, Amy L., et al.
Publicado: (2020)

Comparison of ePlex Respiratory Pathogen Panel with Laboratory-Developed Real-Time PCR Assays for Detection of Respiratory Pathogens
por: Nijhuis, R. H. T., et al.
Publicado: (2017)

Multicenter Evaluation of the ePlex Respiratory Pathogen Panel for the Detection of Viral and Bacterial Respiratory Tract Pathogens in Nasopharyngeal Swabs
por: Babady, N. Esther, et al.
Publicado: (2018)

Performance evaluation of the QIAstat-Dx® Respiratory SARS-CoV-2 Panel
por: Lebourgeois, Samuel, et al.
Publicado: (2021)

Clinical implications of rapid ePlex® Respiratory Pathogen Panel testing compared to laboratory-developed real-time PCR
por: van Rijn, Anneloes L., et al.
Publicado: (2017)

1027. Earlier Is Better: Progress Toward Decreased Time to Optimal Therapy and Improved Antibiotic Stewardship for Gram-positive Bloodstream Infections Through Use of GenMark Dx ePlex system
por: White, Cameron, et al.
Publicado: (2021)

82. Assessment of Clinical Outcomes and Antibiotic Prescribing Patterns Following Implementation of the GenMark ePlex(®) Blood Culture Identification Panel for Gram-positive Bloodstream Infections
por: Wein, Megan, et al.
Publicado: (2021)

Evaluation of point of care testing platform (ePLEX) for respiratory viral diagnosis
por: Guerendiain, Daniel, et al.
Publicado: (2016)

Detecting zoonotic Influenza A using QIAstat-Dx Respiratory SARS-CoV-2 panel for pandemic preparedness
por: Peñarrubia, Luis, et al.
Publicado: (2023)

Evaluation of the ePlex Blood Culture Identification Panels for Detection of Pathogens in Bloodstream Infections
por: Huang, Te-Din, et al.
Publicado: (2019)

Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 panel, a rapid multiplex PCR method for the diagnosis of COVID-19
por: Ishikane, Masahiro, et al.
Publicado: (2022)

Evaluation of the Novel CE-IVD-Marked Multiplex PCR QIAstat-Dx Meningitis/Encephalitis Panel
por: Humisto, Anu, et al.
Publicado: (2023)

1143 GenMark ESensor Respiratory Viral Panel in an Inpatient Pediatric Population
por: Oliver, Sara, et al.
Publicado: (2014)

164. Performance of ePlex® Blood Culture Identification Panels in Clinical Isolates and Characterization of Antimicrobial Stewardship Opportunities
por: Thomas, Jenni, et al.
Publicado: (2023)

Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the First Rapid Multiplex PCR Commercial Assay for SARS-CoV-2 Detection
por: Visseaux, Benoit, et al.
Publicado: (2020)

Evaluation of the QIAstat-Dx Meningitis/Encephalitis Panel, a multiplex PCR platform for the detection of community-acquired meningoencephalitis
por: Sundelin, Thomas, et al.
Publicado: (2023)

Multicenter evaluation of the QIAstat Respiratory Panel—A new rapid highly multiplexed PCR based assay for diagnosis of acute respiratory tract infections
por: Parčina, Marijo, et al.
Publicado: (2020)

2174. Comparison of the Verigene® and the ePlex® Blood Culture Identification Panels for Gram-Positive and Gram-Negative Bloodstream Infections
por: Johnson, J Kristie, et al.
Publicado: (2019)

285. Evaluation of the ePlex® Blood Culture Identification (BCID) Panels for Gram-positive/Gram-negative bacteria and yeasts
por: Chapin, Kimberle, et al.
Publicado: (2020)

Ct values as a diagnostic tool for monitoring SARS-CoV-2 viral load using the QIAstat-Dx® Respiratory SARS-CoV-2 Panel
por: Juanola-Falgarona, Martí, et al.
Publicado: (2022)

Comparative Performance of the Luminex NxTAG Respiratory Pathogen Panel, GenMark eSensor Respiratory Viral Panel, and BioFire FilmArray Respiratory Panel
por: Popowitch, Elena B., et al.
Publicado: (2022)

Evaluation of Microbiological Performance and the Potential Clinical Impact of the ePlex(®) Blood Culture Identification Panels for the Rapid Diagnosis of Bacteremia and Fungemia
por: Bryant, Sabrina, et al.
Publicado: (2020)

653. Comparison of Yeasts identification by Biofire, Culture and ePlex for Quality Assurance purpose
por: lin, jeffrey, et al.
Publicado: (2020)

Verification of analytical bacterial spectrum of QIAstat-Dx(®) GI V2 and Novodiag(®) Bacterial GE+ V2-0 diagnostic panels
por: Engberg, Jørgen, et al.
Publicado: (2021)

Syndromic approach to SARS-CoV-2 detection using QIAstat-Dx SARS-CoV-2 panel from clinical samples
por: Gupta, Akshita, et al.
Publicado: (2021)

Evaluation of the QIAstat-Dx RP2.0 and the BioFire FilmArray RP2.1 for the Rapid Detection of Respiratory Pathogens Including SARS-CoV-2
por: Cassidy, Hayley, et al.
Publicado: (2022)

A Closer Look at the Laboratory Impact of Utilizing ePlex Blood Culture Identification Panels: a Workflow Analysis Using Rapid Molecular Detection for Positive Blood Cultures
por: Tansarli, Giannoula S., et al.
Publicado: (2022)

Performance evaluation of the Panther Fusion® respiratory tract panel
por: Voermans, Jolanda J.C., et al.
Publicado: (2020)

Evaluation of the respiratory NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage and Alinity m Resp-4-Plex assays
por: Quinton, Mikayla, et al.
Publicado: (2022)

Evaluation of commercial ResPlex II v2.0, MultiCode(®)-PLx, and xTAG(®) respiratory viral panels for the diagnosis of respiratory viral infections in adults
por: Balada-Llasat, Joan-Miquel, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_grk0tnot0rin8qtelu4atgaf8s